An exhibition of photographs of the pharmaceutical industry opened in Moscow
A photo exhibition on Shkolnaya Street in Moscow is taking place as part of Industry Month. Vivid footage of the...
A photo exhibition on Shkolnaya Street in Moscow is taking place as part of Industry Month. Vivid footage of the...
The emergence of a large number of generics of lenalidomide for the treatment of multiple myeloma instead of the original...
In October 2023, a pilot project will be launched in Russia, which will allow tracking the origin and place of...
The Ministry of Industry and Trade, together with a number of relevant departments, will launch a pilot project in the...
Despite statements by many foreign pharmaceutical companies about a decrease in activity in Russia, their share in the domestic government...
Despite the reduction in the activity of international pharmaceutical companies in Russia, they continue to defend their patents. So, AstraZeneca...
+ A - "Such normative creativity actually becomes impossible" The State Duma is sparkling with new initiatives. Yesterday, one deputy...
Moscow Mayor Sergei Sobyanin said that the production of medicines in the Russian capital in 2023 increased by two-thirds. During...
The largest Russian drug manufacturer R-Pharm is negotiating the purchase of the Japanese Takeda plant in Yaroslavl. This was reported...
Deputy Prime Minister, Minister of Industry and Trade Denis Manturov and Moscow Mayor Sergei Sobyanin took part in the launch...
Pharmaceutical retailer Rigla (Rigla, Bud Zdorov, Zdravsiti brands), which is part of the Protek group of Vadim Yakunin, acquired the...
According to the results of the first half of 2023, the share of foreign drugs in the Russian market remains...
The developers of the Russian drug dimolegin, used in cardiovascular diseases, have attracted investors. They were the former vice-governor of...
A number of associations of manufacturers and distributors of the pharmaceutical industry are asking the government to instruct the Ministry...
According to the results of the first half of 2023, foreign pharmaceutical companies received seven permits to conduct clinical trials...